Resultados de búsqueda - Ivan Spicka

Benefit of selinexor dose reduction on outcomes with selinexor, bortezomib and dexamethasone in patients with lenalidomide‐refractory multiple myeloma: Subgroup analysis of the BOS... por Sosana Delimpasi, Ivan Špička, Jason P. Butler, Don A. Stevens, Mercedes Gironella Mesa, Ceri Bygrave, Giovanni Marino Merlo, Charles la Porte, Meletios A. Dimopoulos

Enlace del recurso

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma por Barry Paul, Jiri Minarik, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Usmani, Mei Dong, Lin Gu, Carmen Leung, Parul Doshi, Christine Chen, Ludek Pour

Enlace del recurso

An open‐label, first‐in‐human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma... por Prashant Kapoor, Nitya Nathwani, Tomas Jelinek, Ludek Pour, Aurore Perrot, Meletios‐Athanasios Dimopoulos, Shang‐Yi Huang, Ivan Spicka, Saurabh Chhabra, Eben Lichtman, Maria‐Victoria Mateos, Dheepak Kanagavel, Liang Zhao, Helene Guillemin‐Paveau, Sandrine Macé, Helgi van de Velde, Paul G. Richardson

Enlace del recurso